JP2005507387A5 - - Google Patents

Download PDF

Info

Publication number
JP2005507387A5
JP2005507387A5 JP2003528540A JP2003528540A JP2005507387A5 JP 2005507387 A5 JP2005507387 A5 JP 2005507387A5 JP 2003528540 A JP2003528540 A JP 2003528540A JP 2003528540 A JP2003528540 A JP 2003528540A JP 2005507387 A5 JP2005507387 A5 JP 2005507387A5
Authority
JP
Japan
Prior art keywords
compound
dimethylamino
phenyl
group
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003528540A
Other languages
English (en)
Japanese (ja)
Other versions
JP4511176B2 (ja
JP2005507387A (ja
Filing date
Publication date
Priority claimed from DE10146275A external-priority patent/DE10146275A1/de
Application filed filed Critical
Publication of JP2005507387A publication Critical patent/JP2005507387A/ja
Publication of JP2005507387A5 publication Critical patent/JP2005507387A5/ja
Application granted granted Critical
Publication of JP4511176B2 publication Critical patent/JP4511176B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003528540A 2001-09-18 2002-09-18 尿失禁の治療のための、ムスカリン−アンタゴニストと選択されたオピオイドのコンビネーション Expired - Fee Related JP4511176B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10146275A DE10146275A1 (de) 2001-09-18 2001-09-18 Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
PCT/EP2002/010460 WO2003024444A1 (de) 2001-09-18 2002-09-18 Kombination ausgewählter opioide mit muscarin-antagonisten zur therapie der harninkontinenz

Publications (3)

Publication Number Publication Date
JP2005507387A JP2005507387A (ja) 2005-03-17
JP2005507387A5 true JP2005507387A5 (https=) 2009-12-24
JP4511176B2 JP4511176B2 (ja) 2010-07-28

Family

ID=7699618

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003528540A Expired - Fee Related JP4511176B2 (ja) 2001-09-18 2002-09-18 尿失禁の治療のための、ムスカリン−アンタゴニストと選択されたオピオイドのコンビネーション

Country Status (21)

Country Link
US (2) US20040242617A1 (https=)
EP (1) EP1429754B1 (https=)
JP (1) JP4511176B2 (https=)
KR (1) KR100891438B1 (https=)
CN (1) CN100384413C (https=)
AT (1) ATE383854T1 (https=)
AU (1) AU2002342707B2 (https=)
BR (1) BR0212714A (https=)
CA (1) CA2460655C (https=)
DE (2) DE10146275A1 (https=)
EC (1) ECSP045025A (https=)
ES (1) ES2299608T3 (https=)
HU (1) HUP0401485A3 (https=)
IL (2) IL160894A0 (https=)
MX (1) MXPA04002510A (https=)
NO (1) NO333016B1 (https=)
NZ (1) NZ531777A (https=)
PL (1) PL209272B1 (https=)
RU (1) RU2305562C2 (https=)
WO (1) WO2003024444A1 (https=)
ZA (1) ZA200402853B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10146275A1 (de) 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
DE10224108A1 (de) * 2002-05-29 2004-01-29 Grünenthal GmbH 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung
US7410965B2 (en) 2002-05-29 2008-08-12 Gruenenthal Gmbh Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-ol
DE10224556A1 (de) * 2002-05-31 2004-01-08 Grünenthal GmbH 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen
AU2003301184A1 (en) * 2002-12-20 2004-07-22 Dynogen Pharmaceuticals Inc METHODS OF TREATING NON-PAINFUL BLADDER DISORDERS USING Alpha2Delta SUBUNIT CALCIUM CHANNEL MODULATORS
AU2004224322A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. Methods of treating lower urinary tract disorders using smooth muscle modulators and alpha-2-delta subunit calcium channel modulators
DE10356362A1 (de) * 2003-11-28 2005-06-23 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen
MXPA06013270A (es) * 2004-05-14 2007-04-23 Johnson & Johnson Compuestos de opioide carboxamido.
DE102005009217A1 (de) * 2005-02-25 2006-08-31 Grünenthal GmbH Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen
US7884247B2 (en) * 2005-07-22 2011-02-08 Gruenenthal Gmbh Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof
US20070032551A1 (en) * 2005-07-22 2007-02-08 Gruenenthal Gmbh Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof
JP5323480B2 (ja) * 2005-07-22 2013-10-23 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 3−[2−(ジメチルアミノ)メチル−(シクロヘキシ−1−イル)]−フェノールのHCl多形体
DE102007022790A1 (de) * 2007-05-11 2008-11-20 Grünenthal GmbH Axomadol zur Schmerzbehandlung bei Arthrose
RU2673882C1 (ru) * 2008-10-30 2018-12-03 Грюненталь Гмбх Новые и эффективные лекарственные формы тапентадола
WO2011110595A1 (de) 2010-03-10 2011-09-15 Grünenthal GmbH Kristalline salze und/oder cokristalle von o-desmethyltramadol
EP2568965A1 (en) 2010-05-10 2013-03-20 Euro-Celtique S.A. Combination of active loaded granules with additional actives
PH12012502083A1 (en) 2010-05-10 2017-07-26 Euro Celtique Sa Manufacturing of active-free granules and tablets comprising the same
US9700508B2 (en) 2010-05-10 2017-07-11 Euro-Celtique S.A. Pharmaceutical compositions comprising hydromorphone and naloxone
CN103040828B (zh) * 2013-01-07 2015-12-02 常州康普药业有限公司 复方地芬诺酯片及其制备方法
WO2015071380A1 (en) 2013-11-13 2015-05-21 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857194A (en) * 1957-07-05 1960-12-29 Clinical Products Ltd Therapeutic agents comprising ion-exchange resins
NL127065C (https=) 1964-04-22
US5736577A (en) 1995-01-31 1998-04-07 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
DE3012837A1 (de) * 1979-04-10 1980-10-30 Sandoz Ag Analgetische und myotonolytische praeparate
DE3129982A1 (de) * 1981-07-29 1983-02-17 Jutta 8200 Rosenheim Meyer "antiallergikum"
US5073560A (en) 1990-07-20 1991-12-17 Fisons Corporation Spiro-isoxazolidine derivatives as cholinergic agents
DE4041559A1 (de) 1990-12-22 1992-06-25 Boehringer Ingelheim Kg Neue wirkstoffkombinationen
SE9202218D0 (sv) * 1992-07-22 1992-07-22 Kabi Pharmacia Ab Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
PT711289E (pt) * 1993-07-30 2001-02-28 Delta Pharmaceuticals Inc Compostos piperazina utilizados em terapia
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
AU5090796A (en) * 1995-03-03 1996-09-23 Algos Pharmaceutical Corporation Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
DE19525137C2 (de) 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE19609847A1 (de) * 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
WO1998003067A1 (en) 1996-07-19 1998-01-29 Gunnar Aberg S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
AU6747698A (en) * 1997-04-11 1998-11-11 Nippon Shinyaku Co. Ltd. Remedies for frequent urination and urinary incontinence
PE20010623A1 (es) 1999-10-05 2001-07-07 Gruenenthal Chemie Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
PT1257277E (pt) * 2000-02-24 2005-09-30 Pharmacia & Upjohn Co Llc Novas combinacoes de farmacos
DE10059412A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz
DE10146275A1 (de) 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz

Similar Documents

Publication Publication Date Title
JP2005507387A5 (https=)
JP2003523324A5 (https=)
JP5477881B2 (ja) (+)−トラマドール、o−デメチルトラマドール又は(+)−o−デメチルトラマドール、o−デスメチル−n−モノ−デスメチル−トラマドール又は(+)−o−デスメチル−n−モノ−デスメチル−トラマドールを尿失禁の治療に使用する方法
JP5680412B2 (ja) レオヌリンの使用およびその組成物
CN1543344A (zh) 治疗尿失禁的芳基(或杂芳基)氮杂茂甲醇衍生物
RU2286768C2 (ru) Применение 1-фенил-3-диметиламинопропановых соединений для терапии недержания мочи
JP2004538246A5 (https=)
JP2004514691A5 (https=)
RU2280444C2 (ru) Применение 6-диметиламинометил-1-фенилциклогексановых соединений для терапии недержания мочи
KR100835874B1 (ko) 요실금 치료용의 치환된 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물의 용도
JP2005516977A (ja) 尿失禁の処置での4−(2−フルオロフェニル)−6−メチル−2−(1−ピペラジニル)チエノ(2,3−d−ピリミジン)の使用
JP2004527465A5 (https=)
JP4908726B2 (ja) ブプレノルフィンを尿失禁の治療に使用する方法
JP2004524280A5 (https=)
KR101052804B1 (ko) 과활동방광을 치료하기 위한 페녹시아세트산 유도체의 사용
JP2006525318A5 (https=)